AVXLAnavex Life Sciences Corp
AVXL
Anavex Life Sciences Corp24,522
Mkt Cap
$397.6MVolume
352,998.0052W High
$14.4452W Low
$2.86PE Ratio
-8.18AVXL Fundamentals
Price
$4.36Prev Close
$4.45Open
$4.4350D MA
$7.12Beta
1.60Avg. Volume
4.27MEPS (Annual)
-$0.5438P/B
4.07Rev/Employee
$0.00AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life Sciences Corp. (Anavex or the Company) (NASDAQ...
Business Wire·2d ago
Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL)
Anavex Life Sciences (AVXL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·3d ago
Anavex Life Sciences' (AVXL) "Buy" Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued a "buy" rating and set a $24.00 price target on shares of Anavex Life Sciences in a research report on Wednesday...
MarketBeat·8d ago
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Expectations By $0.02 EPS
Anavex Life Sciences (NASDAQ:AVXL - Get Free Report) posted its quarterly earnings data on Tuesday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, beating...
MarketBeat·9d ago
A Preview Of Anavex Life Sciences's Earnings
read more...
Benzinga·11d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·17d ago
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month Low - Here's Why
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month Low - Should You Sell...
MarketBeat·21d ago
Anavex Shares Fall 35% After Negative EU Trend Vote On Alzheimer's Drug
(RTTNews) - Anavex Life Sciences Corp. (AVXL) dropped 35.15% to $3.69, down $2.00, after regulatory updates revealed that the Committee for Medicinal Products for Human Use - CHMP issued a negative...
Nasdaq News: Markets·21d ago